Product Information
CIMETIDINE 200 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2171 per EA under NDC 00378005301. Its NADAC has been published 631 times since Nov 28, 2013.
Strength
200 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378005301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CIMETIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA074246On Market Since
5/17/1994
Pharmacological Classes
Price Statistics
The NADAC for CIMETIDINE 200 MG TABLET has been published 631 times since Nov 28, 2013, and over the history we have for it it has risen 44.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2171 per EA |
|---|---|
| All-time high | $0.3576 (Apr 13, 2016) |
| All-time low | $0.1391 (Jul 23, 2014) |
| 52-week high | $0.2435 |
| 52-week low | $0.2054 |
| Median price | $0.3030 |
| Average price | $0.2841 |
| Largest weekly change | +73.6% (Aug 20, 2014) |
| Weeks tracked | 631 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CIMETIDINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CIMETIDINE 200 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.2171 per EA (NDC 00378005301), effective Jun 24, 2026.
How has the price of CIMETIDINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CIMETIDINE 200 MG TABLET has risen 44.2%. It has been tracked across 631 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIMETIDINE 200 MG TABLET?
Since Nov 28, 2013, the NADAC for CIMETIDINE 200 MG TABLET has ranged from a low of $0.1391 (Jul 23, 2014) to a high of $0.3576 (Apr 13, 2016), with a median of $0.3030 per EA.
Are there cheaper alternatives to CIMETIDINE 200 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CIMETIDINE 200 MG TABLET, but none are currently priced below it.
Who manufactures CIMETIDINE 200 MG TABLET?
CIMETIDINE 200 MG TABLET (NDC 00378005301) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification